Covid-19 Research

Review Article

The European Union Must Act Effectively for a New Plan of Action to Improve the Cardiovascular Health Burden of European citizens: A Narrative Review

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Review Article
Subject Medicine Group
OCLC JBRES Record
Georgiou P Georghiou*, Panos Georghiou, Amalia Georghiou, Andrew Xanthopoulos, Constantinos Lambropoulos and Triposkiadis Filippos
Issue: Volume6-Issue5
Pages: 545-555
Received: 2025-05-16
Accepted: 2025-05-22
Published: 2025-05-28

Abstract

This Narrative Review presents data describing the health burden of Cardiovascular Disease (CVD) within and across the WHO European Region. CVD remains the most common cause of death in the region. Large disparities in data coverage and in country-level morbidity, treatment outcomes and mortality from CVD exist across Europe.

Cardiovascular Diseases (CVD) are the leading cause of death in the European Union (EU) [1]. They cover a broad spectrum of medical disorders that affect the circulatory system (the heart and blood vessels), with atherosclerotic CVD (ASCVD) representing most of the cases. ASCVD is characterized by the abnormal build-up of plaques made of, among other constituents, cholesterol or fatty substances and deposited on the inside walls of a person's arteries. Some of the most devastating manifestations of ASCVD include sudden cardiac death [2], myocardial infarction (heart attack) [3], and stroke (loss of focal neurological function due to infarction or hemorrhage in the relevant part of the brain, retina, or spinal cord) [4].

The COVID-19 pandemic placed unprecedented stress on healthcare systems across the world, and the pandemic severely disrupted medical care for CVD patients and exacerbated cardiovascular-related risk factors [5,6]. The need to increase surge capacity for acute and intensive care beds, combined with the need to prioritize the use of personnel and personal protective equipment for COVID-19 patients led to modifications in regular service provision [7]. Some services were curtailed/postponed due to the number of COVID-19 patients and staff shortages occurred within hospitals and day care centers due to infection/quarantine procedures. Further, patients' access to medical services was hindered due to their own infection/quarantine as well as lockdown or travel restrictions. Existing studies have shown dramatic changes in CVD mortality during the pandemic and a persistent threat may have long-term effects on patients with CVD [8]. The development and implementation of evidence-based preventive and treatment approaches must be supported in all countries by consistent surveillance and monitoring, such that we can quantify the health burden of CVD as well as target interventions and provide impetus for action across Europe.

FullText HTML FullText PDF DOI: 10.37871/jbres2109 Crossmark

Certificate of Publication

Certificate of Publication

Copyright

© 2025 Georghiou GP, et al Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Georghiou GP, Georghiou P, Georghiou A, Xanthopoulos A, Lambropoulos C, Filippos T. The European Union Must Act Effectively for a New Plan of Action to Improve the Cardiovascular Health Burden of European citizens: A Narrative Review. J Biomed Res Environ Sci. 2025 May 28; 6(5): 545-555. doi: 10.37871/jbres2109, Article ID: JBRES2109, Available at: https://www. jelsciences.com/articles/jbres2109.pdf

Subject area(s)

Public HealthCardiovascular Diseases

References

  1. Townsend N, Kazakiewicz D, Lucy Wright F, Timmis A, Huculeci R, Torbica A, Gale CP, Achenbach S, Weidinger F, Vardas P. Epidemiology of cardiovascular disease in Europe. Nat Rev Cardiol. 2022 Feb;19(2):133-143. doi: 10.1038/s41569-021-00607-3. Epub 2021 Sep 8. PMID: 34497402.
  2. Marijon E, Narayanan K, Smith K, Barra S, Basso C, Blom MT, Crotti L, D'Avila A, Deo R, Dumas F, Dzudie A, Farrugia A, Greeley K, Hindricks G, Hua W, Ingles J, Iwami T, Junttila J, Koster RW, Le Polain De Waroux JB, Olasveengen TM, Ong MEH, Papadakis M, Sasson C, Shin SD, Tse HF, Tseng Z, Van Der Werf C, Folke F, Albert CM, Winkel BG. The Lancet Commission to reduce the global burden of sudden cardiac death: a call for multidisciplinary action. Lancet. 2023 Sep 9;402(10405):883-936. doi: 10.1016/S0140-6736(23)00875-9. Epub 2023 Aug 27. PMID: 37647926.
  3. Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction. Lancet. 2017 Jan 14;389(10065):197-210. doi: 10.1016/S0140-6736(16)30677-8. Epub 2016 Aug 5. Erratum in: Lancet. 2017 Jan 14;389(10065):156. doi: 10.1016/S0140-6736(17)30007-7. PMID: 27502078.
  4. Hankey GJ. Stroke. Lancet. 2017 Feb 11;389(10069):641-654. doi: 10.1016/S0140-6736(16)30962-X. Epub 2016 Sep 13. PMID: 27637676.
  5. Song S, Guo C, Wu R, Zhao H, Li Q, Dou JH, Guo FS, Wei J. Impact of the COVID-19 pandemic on cardiovascular mortality and contrast analysis within subgroups. Front Cardiovasc Med. 2024 Feb 7;11:1279890. doi: 10.3389/fcvm.2024.1279890. PMID: 38385134; PMCID: PMC10879411.
  6. Mak IL, Wan EYF, Wong TKT, Lee WWJ, Chan EWY, Choi EPH, Chui CSL, Ip MSM, Lau WCS, Lau KK, Lee SF, Wong ICK, Yu EYT, Lam CLK. The Spill-Over Impact of the Novel Coronavirus-19 Pandemic on Medical Care and Disease Outcomes in Non-communicable Diseases: A Narrative Review. Public Health Rev. 2022 Apr 27;43:1604121. doi: 10.3389/phrs.2022.1604121. PMID: 35574567; PMCID: PMC9091177.
  7. Panteli D, Reichebner C, Rombey T, Berger E, Winkelmann J, Eckhardt H, Nimptsch U, Busse R. Health care patterns and policies in 18 European countries during the first wave of the COVID-19 pandemic: an observational study. Eur J Public Health. 2022 Aug 1;32(4):557-564. doi: 10.1093/eurpub/ckac059. PMID: 35639951; PMCID: PMC9341638.
  8. Mountantonakis SE, Makker P, Saleh M, Coleman KM, Husk G, Jauhar R, Singh V, Epstein LM, Kuvin J. Increased Inpatient Mortality for Cardiovascular Patients During the First Wave of the COVID-19 Epidemic in New York. J Am Heart Assoc. 2021 Aug 17;10(16):e020255. doi: 10.1161/JAHA.120.020255. Epub 2021 Aug 13. PMID: 34387100; PMCID: PMC8475060.
  9. Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D, Gale CP, Maggioni AP, Petersen SE, Huculeci R, Kazakiewicz D, de Benito Rubio V, Ignatiuk B, Raisi-Estabragh Z, Pawlak A, Karagiannidis E, Treskes R, Gaita D, Beltrame JF, McConnachie A, Bardinet I, Graham I, Flather M, Elliott P, Mossialos EA, Weidinger F, Achenbach S; Atlas Writing Group, European Society of Cardiology. European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022 Feb 22;43(8):716-799. doi: 10.1093/eurheartj/ehab892. Erratum in: Eur Heart J. 2022 Feb 22;43(8):799. doi: 10.1093/eurheartj/ehac064. PMID: 35016208.
  10. Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D, Gale CP, Maggioni AP, Petersen SE, Huculeci R, Kazakiewicz D, Rubio VB, Ignatiuk B, Raisi-Estabragh Z, Pawlak A, Karagiannidis E, Treskes R, Gaita D, Beltrame JF, McConnachie A, Bardinet I, Graham I, Flather M, Elliott P, Mossialos EA, Weidinger F, Achenbach S. European Society of Cardiology: cardiovascular disease statistics 2021: Executive Summary. Eur Heart J Qual Care Clin Outcomes. 2022 Jun 6;8(4):377-382. doi: 10.1093/ehjqcco/qcac014. PMID: 35488372.
  11. Global health observatory. World Health Organization, Geneva, Switzerland. WHO. 2022.
  12. Global burden of disease data set. Institute of Health Metrics and Evaluation. 2020.
  13. Stolpe S, Kowall B, Stang A. Decline of coronary heart disease mortality is strongly effected by changing patterns of underlying causes of death: an analysis of mortality data from 27 countries of the WHO European region 2000 and 2013. Eur J Epidemiol. 2021 Jan;36(1):57-68. doi: 10.1007/s10654-020-00699-0. Epub 2020 Nov 28. PMID: 33247420; PMCID: PMC7847455.
  14. Libby P. The changing landscape of atherosclerosis. Nature. 2021 Apr;592(7855):524-533. doi: 10.1038/s41586-021-03392-8. Epub 2021 Apr 21. PMID: 33883728.
  15. Stone NJ, Smith SC Jr, Orringer CE, Rigotti NA, Navar AM, Khan SS, Jones DW, Goldberg R, Mora S, Blaha M, Pencina MJ, Grundy SM. Managing Atherosclerotic Cardiovascular Risk in Young Adults: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022 Mar 1;79(8):819-836. doi: 10.1016/j.jacc.2021.12.016. PMID: 35210038.
  16. Devesa A, Ibanez B, Malick WA, Tinuoye EO, Bustamante J, Peyra C, Rosenson RS, Bhatt DL, Stone GW, Fuster V. Primary Prevention of Subclinical Atherosclerosis in Young Adults: JACC Review Topic of the Week. J Am Coll Cardiol. 2023 Nov 28;82(22):2152-2162. doi: 10.1016/j.jacc.2023.09.817. PMID: 37993206.
  17. European health information gateway. European mortality database. World Health Organization.
  18. Eurostat.
  19. Cenko E, Manfrini O, Fabin N, Dorobantu M, Kedev S, Milicic D, Vasiljevic Z, Bugiardini R. Clinical determinants of ischemic heart disease in Eastern Europe. Lancet Reg Health Eur. 2023 Oct 4;33:100698. doi: 10.1016/j.lanepe.2023.100698. PMID: 37954000; PMCID: PMC10636265.
  20. Luengo-Fernandez R, Walli-Attaei M, Gray A, Torbica A, Maggioni AP, Huculeci R, Bairami F, Aboyans V, Timmis AD, Vardas P, Leal J. Economic burden of cardiovascular diseases in the European Union: a population-based cost study. Eur Heart J. 2023 Dec 1;44(45):4752-4767. doi: 10.1093/eurheartj/ehad583. PMID: 37632363; PMCID: PMC10691195.
  21. González-Muniesa P, Mártinez-González MA, Hu FB, Després JP, Matsuzawa Y, Loos RJF, Moreno LA, Bray GA, Martinez JA. Obesity. Nat Rev Dis Primers. 2017 Jun 15;3:17034. doi: 10.1038/nrdp.2017.34. PMID: 28617414.
  22. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, Goldman L. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010 Feb 18;362(7):590-9. doi: 10.1056/NEJMoa0907355. Epub 2010 Jan 20. PMID: 20089957; PMCID: PMC3066566.
  23. Webb M, Fahimi S, Singh GM, Khatibzadeh S, Micha R, Powles J, Mozaffarian D. Cost effectiveness of a government supported policy strategy to decrease sodium intake: Global analysis across 183 nations. BMJ. 2017;356:i6699. doi: 10.1136/bmj.i6699.
  24. Le Foll B, Piper ME, Fowler CD, Tonstad S, Bierut L, Lu L, Jha P, Hall WD. Tobacco and nicotine use. Nat Rev Dis Primers. 2022 Mar 24;8(1):19. doi: 10.1038/s41572-022-00346-w. PMID: 35332148.
  25. Stătescu C, Clement A, Șerban IL, Sascău R. Consensus and Controversy in the Debate over the Biphasic Impact of Alcohol Consumption on the Cardiovascular System. Nutrients. 2021 Mar 25;13(4):1076. doi: 10.3390/nu13041076. PMID: 33806249; PMCID: PMC8066508.
  26. Piano MR. Alcohol's Effects on the Cardiovascular System. Alcohol Res. 2017;38(2):219-241. PMID: 28988575; PMCID: PMC5513687.
  27. Genovesi S, Giussani M, Orlando A, Battaglino MG, Nava E, Parati G. Prevention of Cardiovascular Diseases in Children and Adolescents. High Blood Press Cardiovasc Prev. 2019 Jun;26(3):191-197. doi: 10.1007/s40292-019-00316-6. Epub 2019 Apr 30. PMID: 31041682.
  28. Saito J, Odawara M, Takahashi H, Fujimori M, Yaguchi-Saito A, Inoue M, Uchitomi Y, Shimazu T. Barriers and facilitative factors in the implementation of workplace health promotion activities in small and medium-sized enterprises: a qualitative study. Implement Sci Commun. 2022 Mar 2;3(1):23. doi: 10.1186/s43058-022-00268-4. PMID: 35236511; PMCID: PMC8889638.
  29. Marteau TM, Hollands GJ, Fletcher PC. Changing human behavior to prevent disease: the importance of targeting automatic processes. Science. 2012 Sep 21;337(6101):1492-5. doi: 10.1126/science.1226918. PMID: 22997327.
  30. Arnold L, Harris K, Weale V. A scoping review of workplace health promotion interventions for chronic diseases in Australia. J Occup Health. 2023 Jan-Dec;65(1):e12417. doi: 10.1002/1348-9585.12417. PMID: 37443451; PMCID: PMC10345237.
  31. Nutbeam D, Lloyd JE. Understanding and Responding to Health Literacy as a Social Determinant of Health. Annu Rev Public Health. 2021 Apr 1;42:159-173. doi: 10.1146/annurev-publhealth-090419-102529. Epub 2021 Oct 9. PMID: 33035427.
  32. Dodd S, Widnall E, Russell AE, Curtin EL, Simmonds R, Limmer M, Kidger J. School-based peer education interventions to improve health: a global systematic review of effectiveness. BMC Public Health. 2022 Dec 2;22(1):2247. doi: 10.1186/s12889-022-14688-3. PMID: 36461024; PMCID: PMC9719233.
  33. 2 social media.
  34. Petkovic J, Duench S, Trawin J, Dewidar O, Pardo Pardo J, Simeon R, DesMeules M, Gagnon D, Hatcher Roberts J, Hossain A, Pottie K, Rader T, Tugwell P, Yoganathan M, Presseau J, Welch V. Behavioural interventions delivered through interactive social media for health behaviour change, health outcomes, and health equity in the adult population. Cochrane Database Syst Rev. 2021 May 31;5(5):CD012932. doi: 10.1002/14651858.CD012932.pub2. PMID: 34057201; PMCID: PMC8406980.
  35. Henderson MJ, Gow ML. A scoping review of health promotion interventions delivered via social media to women of reproductive age. Public Health Nutr. 2023 Dec;26(12):3173-3189. doi: 10.1017/S136898002300246X. Epub 2023 Nov 6. PMID: 37927181; PMCID: PMC10755387.
  36. Kontis V, Mathers CD, Rehm J, Stevens GA, Shield KD, Bonita R, Riley LM, Poznyak V, Beaglehole R, Ezzati M. Contribution of six risk factors to achieving the 25×25 non-communicable disease mortality reduction target: a modelling study. Lancet. 2014 Aug 2;384(9941):427-37. doi: 10.1016/S0140-6736(14)60616-4. Epub 2014 May 2. PMID: 24797573.
  37. NCD global monitoring framework. WHO. 2013.
  38. Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021 Nov;18(11):785-802. doi: 10.1038/s41569-021-00559-8. Epub 2021 May 28. PMID: 34050340; PMCID: PMC8162166.
  39. GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023 Jul 15;402(10397):203-234. doi: 10.1016/S0140-6736(23)01301-6. Epub 2023 Jun 22. Erratum in: Lancet. 2023 Sep 30;402(10408):1132. doi: 10.1016/S0140-6736(23)02044-5. Erratum in: Lancet. 2025 Jan 18;405(10474):202. doi: 10.1016/S0140-6736(25)00053-4. PMID: 37356446; PMCID: PMC10364581.
  40. International diabetes federation.
  41. Walker AF, Graham S, Maple-Brown L, Egede LE, Campbell JA, Walker RJ, Wade AN, Mbanya JC, Long JA, Yajnik C, Thomas N, Ebekozien O, Odugbesan O, DiMeglio LA, Agarwal S. Interventions to address global inequity in diabetes: international progress. Lancet. 2023 Jul 15;402(10397):250-264. doi: 10.1016/S0140-6736(23)00914-5. Epub 2023 Jun 22. PMID: 37356448; PMCID: PMC10726974.
  42. Walker AF, Addala A, Sheehan E, Lal R, Haller M, Cuttriss N, Filipp S, Baer L, Gurka M, Bernier A, Figg L, Westen S, Hood K, Anez-Zabala C, Frank E, Roque X, Maizel J, Maahs D. Using Peer Power to Reduce Health Disparities: Implementation of a Diabetes Support Coach Program in Federally Qualified Health Centers. Diabetes Spectr. 2022 Summer;35(3):295-303. doi: 10.2337/dsi22-0004. Epub 2022 Aug 15. PMID: 36082018; PMCID: PMC9396730.
  43. Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The Global Burden of Cardiovascular Diseases and Risk: A Compass for Future Health. J Am Coll Cardiol. 2022 Dec 20;80(25):2361-2371. doi: 10.1016/j.jacc.2022.11.005. Epub 2022 Nov 9. PMID: 36368511.
  44. Raschi E, Casula M, Cicero AFG, Corsini A, Borghi C, Catapano A. Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events. Pharmacol Ther. 2023 Oct;250:108507. doi: 10.1016/j.pharmthera.2023.108507. Epub 2023 Aug 9. PMID: 37567512.
  45. Guadamuz JS, Shooshtari A, Qato DM. Global, regional and national trends in statin utilisation in high-income and low/middle-income countries, 2015-2020. BMJ Open. 2022 Sep 8;12(9):e061350. doi: 10.1136/bmjopen-2022-061350. PMID: 36691204; PMCID: PMC9462115.
  46. Peiris D, Ghosh A, Manne-Goehler J, Jaacks LM, Theilmann M, Marcus ME, Zhumadilov Z, Tsabedze L, Supiyev A, Silver BK, Sibai AM, Norov B, Mayige MT, Martins JS, Lunet N, Labadarios D, Jorgensen JMA, Houehanou C, Guwatudde D, Gurung MS, Damasceno A, Aryal KK, Andall-Brereton G, Agoudavi K, McKenzie B, Webster J, Atun R, Bärnighausen T, Vollmer S, Davies JI, Geldsetzer P. Cardiovascular disease risk profile and management practices in 45 low-income and middle-income countries: A cross-sectional study of nationally representative individual-level survey data. PLoS Med. 2021 Mar 4;18(3):e1003485. doi: 10.1371/journal.pmed.1003485. PMID: 33661979; PMCID: PMC7932723.
  47. Pirillo A, Norata GD. The burden of hypercholesterolemia and ischemic heart disease in an ageing world. Pharmacol Res. 2023 Jul;193:106814. doi: 10.1016/j.phrs.2023.106814. Epub 2023 Jun 3. PMID: 37271426.
  48. Alfaris N, Alqahtani AM, Alamuddin N, Rigas G. Global Impact of Obesity. Gastroenterol Clin North Am. 2023 Jun;52(2):277-293. doi: 10.1016/j.gtc.2023.03.002. Epub 2023 Apr 7. PMID: 37197873.
  49. Rubino F, Puhl RM, Cummings DE, Eckel RH, Ryan DH, Mechanick JI, Nadglowski J, Ramos Salas X, Schauer PR, Twenefour D, Apovian CM, Aronne LJ, Batterham RL, Berthoud HR, Boza C, Busetto L, Dicker D, De Groot M, Eisenberg D, Flint SW, Huang TT, Kaplan LM, Kirwan JP, Korner J, Kyle TK, Laferrère B, le Roux CW, McIver L, Mingrone G, Nece P, Reid TJ, Rogers AM, Rosenbaum M, Seeley RJ, Torres AJ, Dixon JB. Joint international consensus statement for ending stigma of obesity. Nat Med. 2020 Apr;26(4):485-497. doi: 10.1038/s41591-020-0803-x. Epub 2020 Mar 4. PMID: 32127716; PMCID: PMC7154011.
  50. Bischoff SC, Boirie Y, Cederholm T, Chourdakis M, Cuerda C, Delzenne NM, Deutz NE, Fouque D, Genton L, Gil C, Koletzko B, Leon-Sanz M, Shamir R, Singer J, Singer P, Stroebele-Benschop N, Thorell A, Weimann A, Barazzoni R. Towards a multidisciplinary approach to understand and manage obesity and related diseases. Clin Nutr. 2017 Aug;36(4):917-938. doi: 10.1016/j.clnu.2016.11.007. Epub 2016 Nov 16. PMID: 27890486.
  51. Adams S. Psychopharmacology of Tobacco and Alcohol Comorbidity: a Review of Current Evidence. Curr Addict Rep. 2017;4(1):25-34. doi: 10.1007/s40429-017-0129-z. Epub 2017 Feb 18. PMID: 28357192; PMCID: PMC5350203.
  52. Minian N, Noormohamed A, Lingam M, Zawertailo L, Le Foll B, Rehm J, Giesbrecht N, Samokhvalov AV, Baliunas D, Selby P. Integrating a brief alcohol intervention with tobacco addiction treatment in primary care: qualitative study of health care practitioner perceptions. Addict Sci Clin Pract. 2021 Mar 16;16(1):17. doi: 10.1186/s13722-021-00225-x. PMID: 33726843; PMCID: PMC7968293.
  53. Mannoh I, Hussien M, Commodore-Mensah Y, Michos ED. Impact of social determinants of health on cardiovascular disease prevention. Curr Opin Cardiol. 2021 Sep 1;36(5):572-579. doi: 10.1097/HCO.0000000000000893. PMID: 34397464.
  54. Pries AR, Vardas P, Ballensiefen W, Cosentino F, Dunkel M, Guzik T, Pearson J, Preissner R, Van de Werf F, Wood D. CardioScape-II: the need to map cardiovascular funding patterns in Europe. Cardiovasc Res. 2020 Apr 1;116(5):879-881. doi: 10.1093/cvr/cvaa024. PMID: 32215657.
  55. Gal D, Thijs B, Glänzel W, Sipido KR. Hot topics and trends in cardiovascular research. Eur Heart J. 2019 Jul 21;40(28):2363-2374. doi: 10.1093/eurheartj/ehz282. PMID: 31162536; PMCID: PMC6642725.
  56. Burget M, Bardone E, Pedaste M. Definitions and Conceptual Dimensions of Responsible Research and Innovation: A Literature Review. Sci Eng Ethics. 2017 Feb;23(1):1-19. doi: 10.1007/s11948-016-9782-1. Epub 2016 Apr 18. PMID: 27090147.
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership